Donate Connect
SEARCH

FOP News

Important Press Release and Letter from Ipsen Announcing They Will Reinitiate Dosing in the MOVE Trial

Posted by · March 26, 2020 8:38 AM

Dosing to begin again in patients 14 years of age and older currently enrolled in the trial

Read more Share

STOPFOP Recruitment Paused

Posted by · March 17, 2020 10:55 AM
Read more Share

International Clinical Council on FOP Issues COVID-19 Precautions for FOP Families

Posted by · March 17, 2020 8:55 AM
Read more Share

Coronavirus (COVID-19) Precautions for FOP Families (Updated March 13, 2020)

Posted by · March 13, 2020 3:21 PM
Read more Share

What Should FOP Families Do to Protect Against Coronavirus?

Posted by · March 06, 2020 8:24 AM
Read more Share

Launch of a New Phase 2 Clinical Trial “STOPFOP”

Posted by · March 03, 2020 1:25 PM
Read more Share

University of Michigan Publishes Article Identifying Different Immune Cell Types Post Injury

Posted by · February 14, 2020 10:19 AM
Read more Share

Important Announcement and Letter from Ipsen Regarding the MOVE Trial and a Pause in Dosing

Posted by · January 24, 2020 9:47 AM
Read more Share

Regeneron Releases Phase 2 Trial Results and Shares Next Steps

Posted by · January 15, 2020 10:57 AM
Read more Share

Regeneron Pharmaceutical Releases Results of Phase 2 of the LUMINA-1 Trial

Posted by · January 09, 2020 9:09 AM
Read more Share

Learn More

Is it FOP? Just Diagnosed Registry

Make a Difference

Donate Connect Fundraise
Sign in with Facebook, Twitter or email.
Site by Mosaic • Created with NationBuilder
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter